In vivo PET measurement of expression of dopamine D2 receptor gene injected into rat striatum
体内PET测量大鼠纹状体注射多巴胺D2受体基因的表达
基本信息
- 批准号:10558115
- 负责人:
- 金额:$ 8.45万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
As the basic study of gene therapy, we investigated whether the expression of dopamine DィイD22ィエD2 receptor (DィイD22ィエD2R) gene injected into the rat striatum was evaluated in vivo by positron emission tomography (PET). preliminarily we established that the striatal DィイD22ィエD2R was evaluated by PET with ィイD111ィエD1C-labeled DィイD22ィエD2R-specific ligands by using normal rats and a rat model for striatal neurodegenerative diseases induced by striatal injection of quinolinic acid. To overcome the spatial resolution of PET camera, a technique of PET-MRI registration on the rat brain was developed.PET measurement demonstrated that the uptake of three kinds of DィイD22ィエD2R-specific ligands, [ィイD111ィエD1C]raclopride, [ィイD111ィエD1C]nemonapride and [ィイD111ィエD1C]N-methylspiperone was higher in the striatum injected with the vectors for DィイD22ィエD2R than the contralateral striatum injected with a control vector 2-3 days after injection. The uptake of [ィイD111ィエD1C]SCH 23390, a dopamine DィイD21ィエD2 receptor … More specific ligand, or [ィイD111ィエD1C]β-CIT-FP, a dopamine transporter specific tracer, was not different between bilateral striata, and co-injection of excess unlabeled raclopride inhibited the uptake of [ィイD111ィエD1C]raclopride, suggesting the PET signal reflects the DィイD22ィエD2R-specific gene-expression. These findings were confirmed by ex vivo and in vitro autoradiography. At day 16 the increased uptake of [ィイD111ィエD1C]raclopride declined to basal level, suggesting that the gene expression is temporary.We concluded that PET imaging is capable of detecting adenovirus-mediated gene transfer in vivo. This technique represents a major advance over in vitro ARG analysis of DィイD22ィエD2R binding which must be done post-hoc. PET imaging permits in vivo analysis of the efficiency of DィイD22ィエD2R gene transfer that can be followed longitudinally and related to any functional changes being observed. Such imaging will prove highly valuable for assessment of gene transfer using this and similar vectors. Less
作为基因疗法的基本研究,我们研究了通过阳性发射断层扫描(PET)评估了注入大鼠纹状体中多巴胺D22E D2受体(D22E D2R)基因的表达。我们首先确定,通过使用正常大鼠使用D111E标记的D1C标记的D22E D22E D22E D22E D22E D2R进行评估,该配体使用正常大鼠和大鼠模型用于纹状体神经退行性疾病。 To overcome the spatial resolution of PET camera, a technique of PET-MRI registration on the rat brain was developed.PET measurement demonstrated that the uptake of three kinds of D22R-specific ligands, [D111 D1C]raclopride, [D111 D1C]nemonapride and [D111 D1C]N-methylspiperone was higher in the striatum injection with the vectors for注射后2-3天,D22D2R比对对纹状体注射的对侧纹状体注射。 The uptake of [II D111 D1C]SCH 23390, a dopamine D21 D2 receptor … More specific ligand, or [II D111 D1C]β-CIT-FP, a dopamine transporter specific tracer, was not different between bilateral striata, and co-injection of excess unlabeled raclopride inhibited the uptake of [II D111 D1C]raclopride,提示宠物信号反映了D22E D2R特异性基因表达。这些发现通过体内和体外放射自显影证实。在第16天,[D111E D1C] RACLOPRIDE的摄取量增加到基本水平,表明该基因表达是暂时的。我们得出的结论是,PET成像能够检测体内腺病毒介导的基因转移。该技术代表了对D22E D2R结合的体外ARG分析的重大进展,该分析必须在事后进行。 PET成像允许在体内分析D22E D2R基因转移的效率,该效率可以纵向遵循,并且与观察到的任何功能变化有关。这种成像将证明对于使用此矢量和类似矢量评估基因转移非常有价值。较少的
项目成果
期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hayakawa N., Uemura K., Ishiwata K., Shimada Y., Ogi N., Nagaoka T., Toyama H., Oda K., Tanaka A., Endo K. and Senda M.: "A PET-MRI registration technique for PET studies of the rat brain"Nucl. Med. Biol.. (in press).
Hayakawa N.、Uemura K.、Ishiwata K.、Shimada Y.、Ogi N.、Nagaoka T.、Toyama H.、Oda K.、Tanaka A.、Endo K. 和 Senda M.:“PET-MRI 配准
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishiwata K., Ogi N., Tanaka A. and Senda M.: "Quantitative ex vivo and in vitro receptor autoradiography using ィイD111ィエD1C-labeled ligands and an imaging plate: a study with a dopamine DィイD22ィエD2-like receptor ligand [ィイD111ィエD1C]nemonapride"Nucl. Med. Bi
Ishiwata K.、Ogi N.、Tanaka A. 和 Senda M.:“使用 D111D1C 标记的配体和成像板进行定量离体和体外受体放射自显影:使用多巴胺 D22D D2 样受体配体 [D111D1C]nemonapride 的研究“核医学双
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K Ishiwata et al.: "Quantitative ex vivo and in vitro autoradiographyusing ^<11>C-labeled lignds and imaging plate : a study with a dopamine D2-like receptor ligand [^<11>C]nemonapride"Nuclear Medicine and Biology. 26. 291-296 (1999)
K Ishiwata 等人:“使用 ^ 11 C 标记配体和成像板进行定量离体和体外放射自显影:使用多巴胺 D2 样受体配体 [^ 11 C]nemonapride 进行的研究”核医学和生物学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Ishiwata et al.: "Comparison of three PET dopamine D_2-like receptor ligands, [^<11>C] raclopride, [^<11>C] nemonapride and [^<11>C] N-methylspiperone, in rats"Annals of Nuclear Medicine. 13. 161-167 (1999)
K. Ishiwata 等人:“三种 PET 多巴胺 D_2 样受体配体 [^11C] 雷氯必利、[^11C] 奈莫必利和 [^11C] N-甲基螺哌隆在大鼠体内的比较
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
N. Hayakawa et al.: "A PET-MRI registration technique for PET studies of the rat brain"Nuclear Medicine and Biology. (in press).
N. Hayakawa 等人:“用于大鼠大脑 PET 研究的 PET-MRI 配准技术”核医学与生物学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ISHIWATA Kiichi其他文献
ISHIWATA Kiichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ISHIWATA Kiichi', 18)}}的其他基金
Molecular imaging of metablotropic glutamate receptor type 1 – a first-in-human study
1 型代谢型谷氨酸受体的分子成像
- 批准号:
24390298 - 财政年份:2012
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Organization of PET brain bank
PET脑库的组织
- 批准号:
20390334 - 财政年份:2008
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
New PET diagnosis of adenosine receptors in the brain, heart and skeletal muscle
大脑、心脏和骨骼肌腺苷受体的新 PET 诊断
- 批准号:
16390348 - 财政年份:2004
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
脳シグマ受容体を指標にした加齢・神経変性疾患・脳腫瘍の新しいPET診断法
以大脑西格玛受体为指标的衰老、神经退行性疾病和脑肿瘤的新型 PET 诊断方法
- 批准号:
13557077 - 财政年份:2001
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Proposal of adenosine receptor ligands as new diagnostic probes for myocaridial function by PET
腺苷受体配体作为 PET 心肌功能诊断新探针的建议
- 批准号:
10670883 - 财政年份:1998
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of Biologically Active Nucleosides Labeled with Positron Emitting ^<18>F
正电子发射^<18>F标记的生物活性核苷的开发
- 批准号:
01571193 - 财政年份:1989
- 资助金额:
$ 8.45万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
熏蒸剂处理土壤中胞内与胞外抗生素抗性基因赋存规律及水平转移机制
- 批准号:42307377
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
超表达木聚糖阿拉伯糖转移酶基因促进水稻光合作用和产量提高的生理机制研究
- 批准号:32372218
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
质粒介导下抗生素抗性基因在氮素转化功能菌中的水平转移机理研究
- 批准号:32360316
- 批准年份:2023
- 资助金额:32.00 万元
- 项目类别:地区科学基金项目
组蛋白乙酰转移酶P300招募TET1共同调控ZNF334基因表达在结直肠癌生长中的机制研究
- 批准号:82302970
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基因组导向挖掘的[4,8]双环杂萜类活性成分及其关键异戊烯基转移酶的催化机制研究
- 批准号:82304346
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:
10829717 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Cherenkov luminescence mediated excitation of discrete lanthanide optical probes
切伦科夫发光介导的离散镧系元素光学探针的激发
- 批准号:
10876727 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Optimizing the synthesis of[18F]FTMP for commercial distribution
优化 [18F]FTMP 的合成以进行商业分销
- 批准号:
10601199 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Production of radiometal-based radiopharmaceuticals at a clinical scale via droplet-scale radiochemistry
通过液滴规模放射化学在临床规模生产基于放射性金属的放射性药物
- 批准号:
10697509 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别:
Translational Nonhuman Primate Regenerative Medicine and Gene Therapy/Genome Editing Resource Program
转化非人类灵长类再生医学和基因治疗/基因组编辑资源计划
- 批准号:
10889393 - 财政年份:2023
- 资助金额:
$ 8.45万 - 项目类别: